Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA
Kairos Pharma announced that President and CSO Neil Bhowmick will present and moderate at the 24th Annual Discovery on Target conference in Boston, held Sept. 28 to Oct. 1. Bhowmick will present an oral plenary on KROS-101, a GITR-targeting candidate for solid tumors, and moderate a breakout session on cancer therapy resistance on Sept.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.